SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BioMarin Joins Oligonucleotide Manufacturing Collaboration

BioMarin joined an industrial collaboration with CPI, AstraZeneca, Novo Nordisk and Novartis to scale and commercialize enzyme-driven manufacturing technology for therapeutic oligonucleotides.

BMRN

Related stories